Treatment patterns for AL amyloidosis after frontline daratumumab, bortezomib, cyclophosphamide, and dexamethasone treatment failures
Leukemia, Published online: 09 April 2024; doi:10.1038/s41375-024-02243-5Treatment patterns for AL amyloidosis after frontline daratumumab, bortezomib, cyclophosphamide, and dexamethasone treatment failures (Source: Leukemia)
Source: Leukemia - April 9, 2024 Category: Hematology Authors: Saurabh Zanwar Morie A. Gertz Eli Muchtar Francis K. Buadi Taxiarchis Kourelis Wilson Gonsalves Ronald S. Go Suzanne Hayman Prashant Kapoor Moritz Binder Joselle Cook David Dingli Nelson Leung Yi Lin Rahma Warsame Amie Fonder Miriam Hobbs Yi Lisa Hwa Robe Source Type: research
Pre-frailty after blood or marrow transplantation and the risk of subsequent mortality
Leukemia, Published online: 05 April 2024; doi:10.1038/s41375-024-02238-2Pre-frailty after blood or marrow transplantation and the risk of subsequent mortality (Source: Leukemia)
Source: Leukemia - April 5, 2024 Category: Hematology Authors: Nora Balas Joshua S. Richman Wendy Landier Sadeep Shrestha Katia J. Bruxvoort Lindsey Hageman Qingrui Meng Elizabeth Ross Alysia Bosworth F. Lennie Wong Ravi Bhatia Stephen J. Forman Saro H. Armenian Daniel J. Weisdorf Smita Bhatia Source Type: research
Loss of hematopoietic progenitors heterogeneity is an adverse prognostic factor in lower-risk myelodysplastic neoplasms
Leukemia, Published online: 04 April 2024; doi:10.1038/s41375-024-02234-6Loss of hematopoietic progenitors heterogeneity is an adverse prognostic factor in lower-risk myelodysplastic neoplasms (Source: Leukemia)
Source: Leukemia - April 4, 2024 Category: Hematology Authors: Charles Dussiau Thibault Comont Camille Knosp In ès Vergnolle Clotilde Bravetti Alban Canali Amandine Houvert Laetitia Largeaud Christian Daveaux Laila Zaroili Chlo é Friedrich Isma ël Boussaid Loria Zalmai Carole Almire Odile Rauzy Lise Willems Rudy B Source Type: research
IκBε deficiency accelerates disease development in chronic lymphocytic leukemia
Leukemia, Published online: 04 April 2024; doi:10.1038/s41375-024-02236-4IκBε deficiency accelerates disease development in chronic lymphocytic leukemia (Source: Leukemia)
Source: Leukemia - April 4, 2024 Category: Hematology Authors: Jessica Bordini Chiara Lenzi Michela Frenquelli Alessia Morabito Athanasios Pseftogas Daniela Belloni Larry Mansouri George Tsiolas Eleonora Perotta Pamela Ranghetti Francesca Gandini Francesca Genova Daniel H ägerstrand Georgios Gavriilidis Sofoklis Kei Source Type: research
High-plex imaging and cellular neighborhood spatial analysis reveals multiple immune escape and suppression patterns in diffuse large B-cell lymphoma
Leukemia, Published online: 04 April 2024; doi:10.1038/s41375-024-02239-1High-plex imaging and cellular neighborhood spatial analysis reveals multiple immune escape and suppression patterns in diffuse large B-cell lymphoma (Source: Leukemia)
Source: Leukemia - April 4, 2024 Category: Hematology Authors: David J. Reiss Yumi Nakayama Andrew P. Weng Matthew E. Stokes Laurie Sehn Christian Steidl David W. Scott C. Chris Huang Anita K. Gandhi Source Type: research
A complex interplay of intra- and extracellular factors regulates the outcome of fetal- and adult-derived MLL-rearranged leukemia
Leukemia, Published online: 30 March 2024; doi:10.1038/s41375-024-02235-5A complex interplay of intra- and extracellular factors regulates the outcome of fetal- and adult-derived MLL-rearranged leukemia (Source: Leukemia)
Source: Leukemia - March 30, 2024 Category: Hematology Authors: Maria Jassinskaja Sudip Ghosh Joanna Watral Mina Davoudi Melina Claesson Stern Ugarit Daher Mohamed Eldeeb Qinyu Zhang David Bryder Jenny Hansson Source Type: research
The role of quiescent thymic progenitors in TAL/LMO2-induced T-ALL chemotolerance
Leukemia, Published online: 29 March 2024; doi:10.1038/s41375-024-02232-8The role of quiescent thymic progenitors in TAL/LMO2-induced T-ALL chemotolerance (Source: Leukemia)
Source: Leukemia - March 29, 2024 Category: Hematology Authors: Kevin W. O ’Connor Kensei Kishimoto Irena O. Kuzma Kelsey P. Wagner Jonathan S. Selway Justine E. Roderick Keshab K. Karna Kayleigh M. Gallagher Kai Hu Haibo Liu Rui Li Michael A. Brehm Lihua Julie Zhu David J. Curtis Cedric S. Tremblay Michelle A. Kell Source Type: research
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era – analysis of the European LeukemiaNet Blast Phase Registry
Leukemia, Published online: 28 March 2024; doi:10.1038/s41375-024-02204-yManagement and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era – analysis of the European LeukemiaNet Blast Phase Registry (Source: Leukemia)
Source: Leukemia - March 28, 2024 Category: Hematology Authors: Annamaria Brioli Elza Lomaia Christian Fabisch Tomasz Sacha Hana Klamova Elena Morozova Aleksandra Golos Philipp Ernst Ulla Olsson-Stromberg Daniela Zackova Franck E. Nicolini Han Bao Fausto Castagnetti Elzbieta Patkowska Jiri Mayer Klaus Hirschb ühl Hel Source Type: research
Mitigating immortal-time bias: exploring osteonecrosis and survival in pediatric ALL - AALL0232 trial insights
Leukemia, Published online: 28 March 2024; doi:10.1038/s41375-024-02233-7Mitigating immortal-time bias: exploring osteonecrosis and survival in pediatric ALL - AALL0232 trial insights (Source: Leukemia)
Source: Leukemia - March 28, 2024 Category: Hematology Authors: Shyam Srinivasan Swaminathan Keerthivasagam Source Type: research
Radiotherapy in younger patients with advanced aggressive B-cell lymphoma—long-term results from the phase 3 R-MegaCHOEP trial
Leukemia, Published online: 27 March 2024; doi:10.1038/s41375-024-02231-9Radiotherapy in younger patients with advanced aggressive B-cell lymphoma—long-term results from the phase 3 R-MegaCHOEP trial (Source: Leukemia)
Source: Leukemia - March 27, 2024 Category: Hematology Authors: Michael Oertel Marita Ziepert Fabian Frontzek Nina Nacke Bettina Altmann Maike Nickelsen Bertram Glass Viola Poeschel Christian Ruebe Georg Lenz Norbert Schmitz Hans Theodor Eich Source Type: research
ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?
Leukemia, Published online: 27 March 2024; doi:10.1038/s41375-024-02225-7ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation? (Source: Leukemia)
Source: Leukemia - March 27, 2024 Category: Hematology Authors: Olaf Penack Mouad Abouqateb Christophe Peczynski William Boreland Nicolaus Kr öger Matthias Stelljes Tobias Gedde-Dahl Igor Wolfgang Blau Thomas Schroeder Urpu Salmenniemi Alexander Kulagin R égis Peffault de Latour Stephan Mielke Robert Zeiser Ivan Moi Source Type: research
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients
Leukemia, Published online: 27 March 2024; doi:10.1038/s41375-024-02230-wMolecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients (Source: Leukemia)
Source: Leukemia - March 27, 2024 Category: Hematology Authors: Shai Shimony Jacqueline S. Garcia Julia Keating Evan C. Chen Marlise R. Luskin Maximilian Stahl Donna S. Neuberg Daniel J. DeAngelo Richard M. Stone R. Coleman Lindsley Source Type: research
Proteomics for optimizing therapy in acute myeloid leukemia: venetoclax plus hypomethylating agents versus conventional chemotherapy
Leukemia, Published online: 26 March 2024; doi:10.1038/s41375-024-02208-8Proteomics for optimizing therapy in acute myeloid leukemia: venetoclax plus hypomethylating agents versus conventional chemotherapy (Source: Leukemia)
Source: Leukemia - March 26, 2024 Category: Hematology Authors: Eduardo Sabino de Camargo Magalh ães Stefan Edward Hubner Brandon Douglas Brown Yihua Qiu Steven Mitchell Kornblau Source Type: research
Are there new relevant therapeutic endpoints in the modern era of the BCR::ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia?
Leukemia, Published online: 26 March 2024; doi:10.1038/s41375-024-02229-3Are there new relevant therapeutic endpoints in the modern era of the BCR::ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia? (Source: Leukemia)
Source: Leukemia - March 26, 2024 Category: Hematology Authors: Hagop Kantarjian Susan Branford Massimo Breccia Jorge Cortes Fadi G. Haddad Andreas Hochhaus Timothy Hughes Ghayas C. Issa Elias Jabbour Franck E. Nicolini Koji Sasaki Francois Xavier-Mahon Source Type: research
The Eμ-Ret mouse is a novel model of hyperdiploid B-cell acute lymphoblastic leukemia
Leukemia, Published online: 22 March 2024; doi:10.1038/s41375-024-02221-xThe Eμ-Ret mouse is a novel model of hyperdiploid B-cell acute lymphoblastic leukemia (Source: Leukemia)
Source: Leukemia - March 22, 2024 Category: Hematology Authors: Ali Farrokhi Tanmaya Atre Jenna Rever Mario Fidanza Wendy Duey Samuel Salitra Junia Myung Meiyun Guo Sumin Jo Anuli Uzozie Fatemeh Baharvand Nina Rolf Franziska Auer Julia Hauer Stephan A. Grupp Patrice Eydoux Philipp F. Lange Alix E. Seif Christopher A. Source Type: research
